GHRS logo

GH Research PLC Ordinary Shares


GHRS: GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. Its focus is on developing novel and proprietary 5-Methoxy-N,N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.


Show GHRS Financials

Consumer Interest
SEC Filings

Recent trades of GHRS by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by GHRS's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of GHRS in WallStreetBets Daily Discussion


Recent insights relating to GHRS

CNBC Recommendations

Recent picks made for GHRS stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in GHRS

Corporate Flights

Flights by private jets registered to GHRS